Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details Narrative)

v3.21.4
Stockholders Equity (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Feb. 16, 2021
Apr. 19, 2019
Jun. 30, 2021
Jun. 30, 2021
Dec. 31, 2020
Common stock, par value     $ 0.001 $ 0.001 $ 0.001
Common stock, shares issued     28,144,077 28,144,077 5,218,122
Issuance of Common Stock for research and development agreement       189,753  
Issuance of Common Stock for research and development agreement, amount     $ 327,000 $ 8,779,000  
Issuance of Common Stock for services - consultants       602,458  
Issuance of Common Stock for services - consultants, amount       $ 2,115,000  
Fully vested shares       150,000  
Fully vested shares, amount       $ 1,213,000  
Common stock shares granted for consultants 2,502,518        
Fair value of stock options granted f0r consultants $ 9,679,000        
Common stock shares granted 4,379,407        
Fair value of stock options granted $ 18,621,000        
Issuance of Common Stock in public offering 4,945,000        
Issuance of Common Stock in public offering, amount $ 24,679,000        
Purchase of warrants 5,192,250        
Convertible note payable $ 38,799,000   $ 38,799,000 $ 38,799,000  
Debt conversion debt instrument , shares 11,413,809        
Price per share $ 5.50        
shares of common stock issue     8,261,809 8,261,809  
Notes payable related party     $ 28,083,000 $ 28,083,000  
unissued shares of common stock     3,152,000 3,152,000  
Common stock shares issued upon submission of transfer agent       2,313,116  
Common stock issuable amount       $ 10,716,000  
Common stock, Shares Issued During Period       1,900,060  
Common stock, Shares Issued During Period, Value       $ 7,564,000  
Stockbased compensation to be recognized     $ 8,779,000 $ 8,779,000  
Stockbased compensation to be recognized, shares       2,050,060  
Intrinsic value of warrants     $ 23,937,000 $ 23,937,000  
Aggregate shares of common stock 5,192,250        
Shares of common stock upon exercise of warrants       3,047,818  
Shares of common stock upon exercise of warrants, amount       $ 16,296,000  
Preferred stock, par value     $ 0.01 $ 0.01 $ 0.01
Series K Preferred Stock [Member]          
Preferred stock shares designated 115,000        
Preferred stock, par value $ 0.01        
Series J Preferred Stock [Member]          
Preferred stock shares designated 2,000,000        
Preferred stock, par value   $ 0.01      
shares issued exchange of cancellation of indebtness   840,000   1,513,548  
Conversion price $ 3.40 $ 3.40      
Beneficial conversion percantage   9.99      
Presferred stock shares issued     692,220 692,220 2,353,548
Presferred stock shares outstanding     692,220 692,220 23,535,480
Public offering shares 2,353,548        
Series C Preferred Stock [Member]          
Common stock, shares issued     49,113 49,113  
Conversion price $ 3.40        
Presferred stock shares issued     96,230 96,230  
Public offering shares       300,000